How to Read a Certificate of Analysis (COA) for Research Peptides

What Is a Certificate of Analysis?

A Certificate of Analysis (COA) is a document issued by a quality control laboratory that reports the results of testing performed on a specific batch (lot) of a product. For research peptides, a COA provides objective, analytical evidence of the peptide’s identity, purity, and quality.

A legitimate COA should be available for every lot of peptide sold by a reputable supplier. It is the single most important document for evaluating whether a research peptide meets the specifications required for your work. Without a COA, there is no way to verify that the product is what it claims to be, or that it meets acceptable purity standards.

Key Sections of a Peptide COA

1. Product Identification

The top section of a COA identifies the specific product and lot:

• Product name: The peptide name (e.g., BPC-157, Semaglutide)
• Lot/batch number: A unique identifier for the specific production batch — this is critical for traceability
• Catalog number: The supplier’s internal product code
• Molecular formula and molecular weight: The theoretical chemical composition
• Sequence: The amino acid sequence (often in single-letter code)
• Quantity: The amount of peptide in the vial
• Manufacturing date and expiration date

2. Purity (HPLC)

High-Performance Liquid Chromatography (HPLC) purity is the most important quality metric on a peptide COA. It measures the percentage of the total peptide content that is the desired target sequence, versus impurities such as deletion sequences, truncated sequences, and oxidation products.

How to read it:

• Purity percentage: Expressed as a percentage, e.g., >98%, 99.2%. Higher is better.
• Method: Usually reversed-phase HPLC (RP-HPLC) with UV detection at 214 nm or 220 nm
• Column: C18 is standard for peptide analysis
• Gradient: A description of the mobile phase composition and gradient program

Purity benchmarks:

Purity Level	Typical Use
>95%	Standard research grade
>98%	High purity research
>99%	Pharmaceutical/reference standard grade

What to watch for:

• A COA that states purity as “>95%” without providing the actual measured value is less informative than one reporting “98.7%”
• Some COAs include the HPLC chromatogram (the actual graph) — this is ideal because you can visually inspect the peak shape and any secondary peaks
• Broad or asymmetric peaks may indicate co-eluting impurities that inflate the apparent purity

3. Mass Spectrometry (MS)

Mass spectrometry confirms the identity of the peptide by measuring its molecular weight. The observed mass should match the theoretical mass calculated from the amino acid sequence.

How to read it:

• Method: Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF MS)
• Observed mass (m/z): The measured mass-to-charge ratio
• Expected/theoretical mass: The calculated mass based on the sequence
• Mass accuracy: The difference between observed and expected mass, typically reported in Daltons (Da) or parts per million (ppm)

What to look for:

• The observed mass should be within ±1 Da of the expected mass for ESI-MS, or ±0.1% for MALDI-TOF
• Multiple charge states (e.g., [M+2H]2+, [M+3H]3+, [M+4H]4+) are normal in ESI-MS and help confirm the molecular weight
• If a mass spectrum image is included, the isotope envelope pattern should be consistent with the peptide’s size

4. Amino Acid Analysis (AAA)

Some COAs include amino acid analysis, which hydrolyzes the peptide into its individual amino acids and quantifies each one. The measured amino acid ratios should match the expected ratios from the sequence.

This test is most valuable for confirming the composition of the peptide and determining the net peptide content (accounting for counter-ions, moisture, and salts).

5. Peptide Content / Net Peptide

Lyophilized peptide powders are not 100% peptide by weight. The remaining mass consists of:

• Counter-ions: Acetate (from TFA removal during purification) or chloride salts
• Moisture: Residual water in the lyophilized powder
• Residual solvents: Trace amounts of organic solvents from the purification process

Net peptide content is typically 60-85% of the total powder weight. A vial labeled “5 mg” may contain only 3.5-4.0 mg of actual peptide. This matters for accurate dosing calculations.

6. Endotoxin Testing

Endotoxins are lipopolysaccharides (LPS) from gram-negative bacterial cell walls. They are pyrogenic (fever-causing) and can produce inflammatory responses even at very low concentrations. Endotoxin testing is critical for any peptide that will be used in biological systems.

Methods:

• LAL (Limulus Amebocyte Lysate): The gold standard — uses a blood extract from horseshoe crabs that clots in the presence of endotoxins
• Kinetic turbidimetric LAL: Quantitative variant that measures the rate of clot formation
• rFC (Recombinant Factor C): A newer, animal-free alternative

Acceptable limits:

• Research peptides: <5 EU/mg (Endotoxin Units per milligram) is a common specification
• Pharmaceutical grade: <0.25 EU/mg

7. Residual Solvents

Peptide synthesis and purification use organic solvents (typically acetonitrile, TFA, DMF, and DCM). A COA may report residual solvent levels, particularly for higher-quality products.

ICH Q3C guidelines classify solvents by toxicity:

• Class 2 (limit use): Acetonitrile (<410 ppm), DMF (<880 ppm), DCM (<600 ppm)
• Class 3 (low risk): TFA, ethanol, acetone — generally less concerning

8. Appearance and Solubility

Some COAs include physical observations:

• Appearance: Should state “white to off-white lyophilized powder” for most peptides
• Solubility: Notes on recommended reconstitution solvents and expected clarity

How to Verify a COA Is Legitimate

Not all COAs are created equal. Some low-quality suppliers provide generic, fabricated, or recycled COAs. Here are red flags and verification strategies:

Red Flags

• No lot number, or the lot number does not match your vial
• No testing laboratory identified — a legitimate COA should state who performed the analysis
• Identical COAs for every lot — if the purity, mass, and all values are identical across multiple lot numbers, the data may be fabricated
• No chromatogram or spectrum images — while not all COAs include raw data, their inclusion significantly increases credibility
• Unusually round numbers — a purity of exactly “99.00%” across every lot is suspicious; real analytical data has natural variation (e.g., 98.73%, 99.14%, 98.91%)
• Missing test dates or dates that predate the lot number

Verification Strategies

1. Cross-reference the lot number on your vial with the COA provided. They must match.
2. Request the COA before purchase — reputable suppliers provide COAs proactively or upon request.
3. Check for third-party testing — COAs from independent, accredited laboratories (ISO 17025, GLP-compliant) carry more weight than in-house testing.
4. Compare across lots — request COAs from multiple lots and look for natural variation in the data. Identical values across lots suggest fabrication.
5. Send a sample for independent testing — if you have access to an analytical laboratory, independent verification of purity and identity is the definitive check.

What a Good COA Looks Like

A high-quality COA from a reputable peptide supplier should include, at minimum:

• Peptide name and amino acid sequence
• Unique lot number matching the product label
• HPLC purity with actual percentage (not just “>95%”) and method details
• Mass spectrometry confirmation with observed and expected mass
• Net peptide content
• Endotoxin testing results (for injectable-grade peptides)
• Testing laboratory name and date
• Ideally: HPLC chromatogram and MS spectrum images

Frequently Asked Questions

What purity should I look for in a research peptide?

For most research applications, >95% HPLC purity is acceptable. For sensitive research or in vivo applications, >98% is preferred. Pharmaceutical reference standards are typically >99%.

My COA shows 98% HPLC purity. What is the other 2%?

The remaining 2% consists of closely related impurities — typically deletion sequences (peptides missing one or more amino acids from the synthesis), truncated sequences, oxidized forms, and deamidation products. These are inherent to solid-phase peptide synthesis and are normal at low levels.

Does every vial come with its own COA?

No — a single COA covers an entire production lot. Multiple vials from the same lot share one COA. The lot number on your vial should match the COA.

Can I trust a COA from the supplier’s own lab?

In-house COAs from reputable suppliers with documented quality systems are generally reliable. However, third-party COAs from accredited independent laboratories provide an additional layer of confidence. The best practice is to verify with independent testing when the research application is critical.

What if the supplier cannot provide a COA?

Do not purchase peptides from suppliers who cannot provide a lot-specific COA. The absence of a COA is the single most significant quality red flag in the peptide supply chain.

References

1. ICH Q3C(R8). “Guideline for Residual Solvents.” International Council for Harmonisation. 2021.
2. USP <85>. “Bacterial Endotoxins Test.” United States Pharmacopeia.
3. ICH Q6A. “Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products.” International Council for Harmonisation.
4. Verbeke R, et al. “Quality assessment of research-grade peptides.” Analytical Chemistry. 2019.
5. FDA Guidance. “Analytical Procedures and Methods Validation for Drugs and Biologics.” 2015.
6. Grant GA. “Synthetic Peptides: A User’s Guide.” Oxford University Press. 2002.
7. Coin I, et al. “Solid-phase peptide synthesis: from standard procedures to the synthesis of difficult sequences.” Nature Protocols. 2007;2(12):3247-3256.
8. USP <621>. “Chromatography.” United States Pharmacopeia.